Skip to main content
. 2000 Jan 18;97(2):793–798. doi: 10.1073/pnas.97.2.793

Table 4.

Morphometric analyses

Treatment Body weight, mm LV weight, g LV/BW × 103 Lung wet/dry weight ratio LV/TL × 103, g/mm
Sham + Ad.βgal 578  ±  34 1.09  ±  0.14 1.9  ±  0.1 3.7  ±  0.5 26.4  ±  5
Failing + Ad.βgal 596  ±  41 1.82  ±  0.22* 3.1  ±  0.1* 5.6  ±  0.7* 44.3  ±  6*
Sham + SERCA2a 559  ±  44 1.14  ±  0.15 2.1  ±  0.1 3.6  ±  0.4 28.5  ±  4
Failing + SERCA2a 611  ±  51 1.85  ±  0.17* 3.0  ±  0.2* 4.7  ±  0.5* 45.1  ±  5*

LV, left ventricle; *, P < 0.05 compared to Sham + Ad.βgal; †, P < 0.05 compared to Sham + Ad.SERCA2a.